Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London. The study will be the first time the vaccine has been trialled in humans and will test whether it is well-tolerated and produces an effective immune response against COVID-19. Imperial’s vaccine candidate is […]
Read More… from Imperial to begin first human trials of new Covid-19 vaccine
Imperial College London has formed a new social enterprise VacEquity Global Health (VGH) to bring its COVID-19 vaccine to the world. For the UK and low-income countries abroad, Imperial and VGH will waive royalties and charge only modest cost-plus prices to sustain the enterprise’s work, accelerate global distribution and support new research. The social enterprise’s […]
Read More… from Imperial social enterprise to accelerate low-cost COVID-19 vaccine
The Vaccines Manufacturing and Innovation Centre (VMIC), a not-for-profit organisation established to provide the UK’s first strategic vaccine development and advanced manufacturing capability has signed its first industry partnership agreement with gene and cell therapy group Oxford Biomedica plc. The agreement signed today involves the organisations collaborating to enable scaled-up manufacture of viral vector based […]
Read More… from Vaccines Manufacturing and Innovation Centre Signs First Industry Partnership
COVID-19 Series: Vaccines Episode 20 will be broadcast on zoom on Tue 9 Jun 2020 from 12:30pm to 1:00pm. Key speakers: Professor Robin Shattock, Head of Mucosal Infection and Immunity at Imperial College London. Dr Thomas Breuer, Chief Medical Officer at GSK Vaccines. A safe and effective vaccine against COVID-19 is generally regarded as the only way […]
University of Oxford researchers have begun testing a COVID-19 vaccine in human volunteers in Oxford today. Around 1,110 people will take part in the trial, half receiving the vaccine and the other half (the control group) receiving a widely available meningitis vaccine. Of the first two volunteers to take part today, one will likewise receive […]
New evidence published in the Cochrane Library today finds MMR, MMRV and MMR+V vaccines are effective and that they are not associated with increased risk of autism. Measles, mumps, rubella and varicella (also known as chickenpox) are infectious diseases caused by viruses. They are most common in children and young adults, and can lead to […]
Read More… from Cochrane supports safety & effectiveness of MMR vaccines
On the 13th April, the WHO made a public statement for collaboration on COVID-19 vaccine development. On 31 December 2019, the World Health Organization (WHO) was informed of a cluster of cases of pneumonia of unknown cause detected in Wuhan City, Hubei Province of China. Chinese authorities identified the SARS-CoV-2 as the causative virus on […]
Aluminium is Toxic In 1984, as an undergraduate at the University of Stirling, Scotland and while carrying out my first piece of independent research, I watched for the first time a fish, a salmon parr, die from acute aluminium toxicity. The whole process took less than forty-eight hours. Within six hours, the fish showed signs […]
Read More… from Infants are Uniquely Vulnerable to Aluminium in Vaccines
I have been researching human exposure to aluminium for over thirty-five years. I am (sometimes affectionately) known as Mr Aluminium. About ten years ago, I became interested in aluminium adjuvants and specifically how they help to potentiate the immune response in vaccination. Funded initially by the Medical Research Council (Nanotoxicity of Aluminium Adjuvants) we set […]
Read More… from Aluminium Adjuvants in Vaccines: Missing Information
It would seem that I am a rare breed. I research the safety of aluminium adjuvants used in vaccines (See; Safety concerns around aluminium adjuvants). In doing so, I acknowledge that not all vaccines that include an aluminium adjuvant are completely safe for all recipients. This is not an opinion that is openly shared by […]